Outset Medical annual return on equity
2021
2022
2023
2024
2025
Outset Medical Return on Equity (ROE) Growth & History (OM)
Outset Medical's return on equity was −106.20% for fiscal 2025.
View full Outset Medical company overviewOutset Medical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −106.20% | +64.77 pp |
| 2024 | 2024-12-31 | −170.97% | −77.28 pp |
| 2023 | 2023-12-31 | −93.69% | −41.13 pp |
| 2022 | 2022-12-31 | −52.56% | −15.01 pp |
| 2021 | 2021-12-31 | −37.55% | — |
Outset Medical quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −17.29% | −5.87 pp |
| Q1 2026 | 2026-03-31 | −15.91% | +10.31 pp |
| Q4 2025 | 2025-12-31 | −14.47% | +54.22 pp |
| Q3 2025 | 2025-09-30 | −12.01% | +35.99 pp |
| Q2 2025 | 2025-06-30 | −11.42% | +31.17 pp |
| Q1 2025 | 2025-03-31 | −26.22% | +10.75 pp |
| Q4 2024 | 2024-12-31 | −68.70% | −40.62 pp |
| Q3 2024 | 2024-09-30 | −48.00% | −20.44 pp |
| Q2 2024 | 2024-06-30 | −42.59% | −20.53 pp |
| Q1 2024 | 2024-03-31 | −36.97% | −17.95 pp |
| Q4 2023 | 2023-12-31 | −28.08% | −12.29 pp |
| Q3 2023 | 2023-09-30 | −27.56% | −13.71 pp |
| Q2 2023 | 2023-06-30 | −22.06% | −8.67 pp |
| Q1 2023 | 2023-03-31 | −19.02% | −8.77 pp |
| Q4 2022 | 2022-12-31 | −15.79% | −5.26 pp |
| Q3 2022 | 2022-09-30 | −13.85% | −6.60 pp |
| Q2 2022 | 2022-06-30 | −13.38% | −5.19 pp |
| Q1 2022 | 2022-03-31 | −10.25% | −0.80 pp |
| Q4 2021 | 2021-12-31 | −10.52% | −1.14 pp |
| Q3 2021 | 2021-09-30 | −7.25% | — |
| Q2 2021 | 2021-06-30 | −8.19% | — |
| Q1 2021 | 2021-03-31 | −9.45% | — |
| Q4 2020 | 2020-12-31 | −9.38% | — |
Outset Medical return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Outset Medical's return on equity decreased from −37.55% to −106.20%, a change of −68.65 percentage points. The latest reported quarter, Q2 2026, shows −17.29%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Outset Medical source filings ↗